Terbinafine Compared to Griseofulvin in Children With Tinea Capitis

Status Completed

Clinical Trial Summary

Tinea capitis is a dermatophyte infection of the scalp hair follicles, which occurs primarily in children. Hair loss, hair breakage, scaling, plus various degrees of erythema, pustules and pruritus are the primary clinical signs which can be associated with tinea capitis. The infection is caused by a relatively small group of dermatophytes in the genera Trichophyton and Microsporum.

Terbinafine hydrochloride is a synthetic allylamine derivative antifungal agent. This study will evaluate the efficacy and safety of terbinafine in children with tinea capitis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00117767
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 3
Start date	June 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00224926` - The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation	N/A
Completed	`NCT04144491` - Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda	N/A
Completed	`NCT00645242` - A Study Of Diflucan In Children With Ringworm Of The Scalp	Phase 3
Completed	`NCT02725255` - Design and Clinical Evaluation of a School Meal With Deworming Properties	Phase 2/Phase 3
Completed	`NCT02550496` - Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis	N/A
Completed	`NCT00127868` - Selenium Sulfide, Ketoconazole and Ciclopirox Shampoo as Additional Treatments for Tinea Capitis (Scalp Ringworm)	N/A
Completed	`NCT00117754` - Terbinafine Compared to Griseofulvin in Children With Tinea Capitis	Phase 3
Withdrawn	`NCT02658292` - Safety and Efficacy of NAFT900 in Children With Tinea Capitis	Phase 2